Actelion (Switzerland)

Actelion (Switzerland)

Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland.Actelion focuses on the manufacture of drugs that treat rare diseases and orphan diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Actelion (Switzerland), Switzerland, covering academic research published from 2000 to 2021. Read More.


Open Access Percentage

40%


Total
Publications

995


Total Open
Publications

399


Total
Citations

36k


Open Access
Percentage

40%


Total
Publications

995


Total Open
Publications

399


Total
Citations

36k

Wikipedia

Website

Download

Breakdown

16% 19% 5% 60%

Publisher Open

16%

Both

19%

Other Platform Open

5%

Closed

60%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Open

Closed

Publisher Open

27%OA Journal

OA Journal 27%

92

Hybrid 41%

142

No Guarantees 32%

112

Other Platform Open

Domain 83%

203

Institution 37%

90

Public 14%

33

Other Internet 6%

14

Preprint 2%

5

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
202
Europe PMC
Domain
174
Semantic Scholar
Public
27
University College London - UCL Discovery
Institution
15
University of Oxford - Oxford Academic Notes & Queries
Institution
14
Alma Mater Studiorum Università di Bologna - Archivio istituzionale della ricerca - Alma Mater Studiorum Università di Bologna
Institution
8
University of Zurich - Zurich Open Repository and Archive
Institution
7
University of Geneva - Archive ouverte UNIGE
Institution
6
unimelb.edu.au OAI-PMH Repository
Institution
6
INFN Catania - INFM-OAR
Institution
6
1 / 8

Data updated 27 September 2022

Share

Share

Share